BioSpace News Archive

Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome, today announced that John McHutchison, AO, MD, Chief Executive Officer and President will make a corporate presentation at the Jefferies London Healthcare Conference on Wednesday, November 20, 2019 at 9:20am GMT.

Foamix Pharmaceuticals Ltd., a specialty pharmaceutical company, announced the completion of Phase 2 clinical trial enrollment of FCD105 for the treatment of moderate-to-severe acne vulgaris.

Nisonic AS, a startup co-founded by SINTEF and Cofounder in Norway, aims to make intracranial pressure assessment as simple and easy as measuring body temperature.

Collaboration between drug companies and contract research partners drives innovation in evolving business environment

Many female athletes encounter higher concussion rates than their male counterparts, according to two studies conducted by researchers at Hospital for Special Surgery

AADC deficiency patients are often misdiagnosed as having other neurological conditions such as cerebral palsy n. Ch

Solutions Serve Facilities Across the Healthcare Industry

Data presented at the 2019 American Heart Association Scientific Sessions

Recognized leader in sustainable solutions for agriculture unveils pioneering rhizosphere innovation at Biostimulants World Congress

Scandinavian ChemoTech and its CEO Mohan Frick has been selected to present its Tumour Specific Electroporation at the Emerging Medtech Summit in California, USA.